Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of pretreatment HIV drug resistance in Mwanza, Tanzania.

The Journal of antimicrobial chemotherapy - 1 Dec 2018

Rudovick Ladius, Brauner Jan M, Englert Johanna, Seemann Carolina, Plugaru Karina, Kidenya Benson R, Kalluvya Samuel E, Scheller Carsten, Kasang Christa

Abstract excerpt

Background: In a 2008-10 study, we found a pretreatment HIV drug resistance (PDR) prevalence of 18.2% in patients at Bugando Medical Centre (BMC) in Mwanza, Tanzania. Objectives: To determine the prevalence of PDR and transmitted HIV drug resistance (TDR) in patients visiting the BMC from 2013 to 2015. Methods: Adult outpatients were sequentially enrolled into two groups, separated by whether they were initiating...

Topics

Join the communities discussing this publication.

Cross-Sectional Studies
Drug Resistance, Viral
HIV
HIV Infections
Mutation, Missense

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

pol Gene Products, Human Immunodeficiency Virus

Source

Identifiers

PMID: 30165451
DOI: 10.1093/jac/dky332

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of pretreatment HIV drug resistance in Mwanza, Tanzania.PMID 30165451Read ↗

Increasing Prevalence of HIV Pretreatment Drug Resistance in Women But Not Men in Rural Uganda During 2005-2013.Semantic proximity Read ↗

Surveillance of HIV-1 drug resistance in Tanzania across the pre- and post-dolutegravir eras: A systematic review and meta-analysis.Semantic proximity Read ↗

Patterns of acquired HIV-1 drug resistance mutations and predictors of virological failure in Moshi, Northern Tanzania.Semantic proximity Read ↗

Prevalence and factors associated with drug resistance mutations among HIV - 1 patients failing to achieve virological suppression on second line treatment in Tanzania.Semantic proximity Read ↗

HIV virologic response, patterns of drug resistance mutations and correlates among adolescents and young adults: A cross-sectional study in Tanzania.Semantic proximity Read ↗

Molecular Epidemiology and Trends in HIV-1 Transmitted Drug Resistance in Mozambique 1999-2018.Semantic proximity Read ↗

Prevalence of pretreatment HIV drug resistance in Cameroon following a nationally representative WHO survey.Semantic proximity Read ↗

Pretreatment and Acquired Antiretroviral Drug Resistance Among Persons Living With HIV in Four African Countries.Semantic proximity Read ↗

Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013-2014.Semantic proximity Read ↗

HIV-1 Pretreatment and Acquired Antiretroviral Drug Resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique Running title: Pretreatment and Acquired HIV Drug Resistance in MozambiqueSemantic proximity Read ↗

HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique.Semantic proximity Read ↗

Pre-treatment drug resistance among patients initiating antiretroviral therapy (ART) in Zimbabwe: 2008-2010.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.